Delivery Order SPE2DB22D3501-SPE2DB24FWL00
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a ceiling value of $5,980.62 and a period of performance through May 7, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The total ceiling value of the contract is $17,631.41, and it has a firm fixed price pricing type. The contract has a completion date of June 14, 2024. This contract is not designated as a set-aside. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,778,830 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $9,654.84 and a period of performance through September 13, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide critical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a ceiling value of $2,076.90 and a completion date of March 19, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,131.20 and is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. This contract award is not designated as a set-aside, indicating open...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,379.93 and is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a critical medical commodity. The contract is a Firm Fixed Price type and has an ultimate completion date of May 15, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,954,863 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $5,140.33 and a performance period through March 14, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a ceiling value of $2,714.88 and a performance period through June 13, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,688.31, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product, to support federal healthcare programs. The contract is a firm fixed-price, delivery order type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,705.55, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. The contract type is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 8, 2024. This contract award is not designated as a set-aside....